Artificial intelligence (AI) and Machine learning are transforming drug discovery in prostate cancer by addressing the biological heterogeneity, therapeutic resistance, and inefficiencies inherent in traditional pipelines. By integrating multi-omics, imaging, and clinical datasets, Artificial intelligence/Machine learn...
A. Musa, Muhammad Lawan Wasaram, Kashim Ibrahim Muhammad et al.· International Journal of App...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.